Cargando…
In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development
Molecular engineering to increase the percentage identity to common human immunoglobulin sequences of non-human therapeutic antibodies and scaffolds has become standard practice. This strategy is often used to reduce undesirable immunogenic responses, accelerating the clinical development of candida...
Autores principales: | Steven, John, Müller, Mischa R., Carvalho, Miguel F., Ubah, Obinna C., Kovaleva, Marina, Donohoe, Gerard, Baddeley, Thomas, Cornock, Dawn, Saunders, Kenneth, Porter, Andrew J., Barelle, Caroline Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5660122/ https://www.ncbi.nlm.nih.gov/pubmed/29109729 http://dx.doi.org/10.3389/fimmu.2017.01361 |
Ejemplares similares
-
Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis
por: Kovaleva, Marina, et al.
Publicado: (2017) -
In Vitro ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA: An Encouraging Milestone to Further Clinical Drug Development
por: Ubah, Obinna C., et al.
Publicado: (2020) -
Uveitis Therapy With Shark Variable Novel Antigen Receptor Domains Targeting Tumor Necrosis Factor Alpha or Inducible T-Cell Costimulatory Ligand
por: Pepple, Kathryn L., et al.
Publicado: (2019) -
The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles
por: Fernández-Quintero, Monica L., et al.
Publicado: (2022) -
Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3
por: Cabanillas-Bernal, Olivia, et al.
Publicado: (2019)